menu icon
PGDip
Queen Mary University of London
Cancer and Molecular and Cellular Biology PGDip
Queen Mary University of London

Cancer and Molecular and Cellular Biology PGDip

QUEEN MARY UNIVERSITY OF LONDON

Compare

Different course options

Full time | Charterhouse Square | 9 months | SEP

Study mode

Full time

Duration

9 months

Start date

SEP

Key information
DATA SOURCE : IDP Connect

Qualification type

Graduate Diploma - Grad Dip

Subject areas

Cell Biology Molecular Biology

Course Summary

Our programme will give you a grounding in the molecular and cellular biology that underpins cancer biology and research. You’ll discover how the treatment and diagnosis of cancer has advanced and how new therapies are developed, evaluated and implemented. Study and contribute to the latest developments in the treatment of cancerTaught by experts from Barts Cancer Institute, one of four partners in the Cancer Research UK City of London Centre, a world-leading hub dedicated to cancer biotherapeuticsPart-time option, so you can fit your studies around your other commitmentsAn ideal career boost if you want to work in research or biotech. What you'll studyThis Postgraduate Diploma gives you a detailed and thorough understanding of the molecular and cellular basis of cancer and its treatments. You’ll also develop a deep knowledge of cancer biology, pathology, pharmacology and drug development, as well as a variety of other scientific and transferable skills. By studying on the Cancer and Molecular and Cellular Biology pathway, you’ll be equipping yourself with the tools to complete academic research at MSc level, or improve your career prospects in a clinical, pharmaceutical or diagnostic setting. This programme is delivered by the Barts Cancer Institute, a Cancer Research UK centre of excellence and part of the Cancer Research UK City of London Centre.

Modules

Biological Therapies - Core
This module will provide an understanding of the science behind the biological therapies of cancer, and an up-to-date review of the current status of preclinical and clinical trials. The module will also provide an insight into the ways that laboratory research is translated into clinical trials. By the end of the module you will be able to: Understand the basis of biological therapy of cancer; Understand the role of non-malignant cells and mediators in cancer growth and progression
Cancer Biology - Core
Cancer Pharmacology - Core
Dissertation - Core
Drug Development - Core
Genomic Approaches to Cancer - Core
Molecular Diagnostics and Therapeutics - Core
Research Lab Skills - Core
Research Methods - Core

Tuition fees

UK fees
Course fees for UK students

For this course (month)

£956

International fees
Course fees for EU and international students

For this course (month)

£2,222

Entry requirements

2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution. Applicants with a 2:2 degree will be considered on an individual basis. Other routes: The programme is open to graduate scientists, clinicians and other medical professionals working in healthcare, the pharmaceutical industry or contract research organisations.

University information

Queen Mary University of London-Overview
Uni profile Get prospectus

Queen Mary University of London is a place where every difference is celebrated – where unique perspectives are not just welcomed, but essential. Queen Mary students join a community where individuality fuels progress, and distinct experiences shape a richer, more dynamic learning environment. A member of the prestigious Russell Group, Queen Mary has five campuses in the city of London and an international network of satellite campuses in...more